Design and methods for a quasi-experimental pilot study to evaluate the impact of dual active ingredient insecticide-treated nets on malaria burden in five regions in sub-Saharan Africa
Authors: Gansané Adama , Candrinho Baltazar , Mbituyumuremyi Aimable , Uhomoibhi Perpetua , NFalé Sagnon , Mohammed Audu Bala , Guelbeogo Wamdaogo Moussa , Sanou Antoine , Kangoye David , Debe Siaka , Kagone Moubassira , Hakizimana Emmanuel , Uwimana Aline , Tuyishime Albert , Ingabire Chantal M. , Singirankabo Joseph H. , Koenker Hannah , Marrenjo Dulcisaria , Abilio Ana Paula , Salvador Crizologo , Savaio Binete , Okoko Okefu Oyale , Maikore Ibrahim , Obi Emmanuel , Awolola Samson Taiwo , Adeogun Adedapo , Babarinde Dele , Ali Onoja , Guglielmo Federica , Yukich Joshua , Scates Sara , Sherrard-Smith Ellie , Churcher Thomas , Fornadel Christen , Shannon Jenny , Kawakyu Nami , Beylerian Emily , Digre Peder , Tynuv Kenzie , Gogue Christelle , Mwesigwa Julia , Wagman Joseph , Adeleke Monsuru , Adeolu Ande Taiwo , Robertson Molly 
Published: January 2022

Background

Vector control tools have contributed significantly to a reduction in malaria burden since 2000, primarily through insecticidal-treated bed nets (ITNs) and indoor residual spraying. In the face of increasing insecticide resistance in key malaria vector species, global progress in malaria control has stalled. Innovative tools, such as dual active ingredient (dual-AI) ITNs that are effective at killing insecticide-resistant mosquitoes have recently been introduced. However, large-scale uptake has been slow for several reasons, including higher costs and limited evidence on their incremental effectiveness and cost-effectiveness. The present report describes the design of several observational studies aimed to determine the effectiveness and cost-effectiveness of dual-AI ITNs, compared to standard pyrethroid-only ITNs, at reducing malaria transmission across a variety of transmission settings.

Methods

Observational pilot studies are ongoing in Burkina Faso, Mozambique, Nigeria, and Rwanda, leveraging dual-AI ITN rollouts nested within the 2019 and 2020 mass distribution campaigns in each country. Enhanced surveillance occurring in select study districts include annual cross-sectional surveys during peak transmission seasons, monthly entomological surveillance, passive case detection using routine health facility surveillance systems, and studies on human behaviour and ITN use patterns. Data will compare changes in malaria transmission and disease burden in districts receiving dual-AI ITNs to similar districts receiving standard pyrethroid-only ITNs over three years. The costs of net distribution will be calculated using the provider perspective including financial and economic costs, and a cost-effectiveness analysis will assess incremental cost-effectiveness ratios for Interceptor® G2, Royal Guard®, and piperonyl butoxide ITNs in comparison to standard pyrethroid-only ITNs, based on incidence rate ratios calculated from routine data.

Conclusions

Evidence of the effectiveness and cost-effectiveness of the dual-AI ITNs from these pilot studies will complement evidence from two contemporary cluster randomized control trials, one in Benin and one in Tanzania, to provide key information to malaria control programmes, policymakers, and donors to help guide decision-making and planning for local malaria control and elimination strategies. Understanding the breadth of contexts where these dual-AI ITNs are most effective and collecting robust information on factors influencing comparative effectiveness could improve uptake and availability and help maximize their impact.